EOSINOPHILIC ESOPHAGITIS (EOE)
Clinical trials for EOSINOPHILIC ESOPHAGITIS (EOE) explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ESOPHAGITIS (EOE) trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ESOPHAGITIS (EOE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with swallowing trouble: drug targets esophageal inflammation
Disease control CompletedThis study tested dupilumab (Dupixent) in 102 children with active eosinophilic esophagitis, a condition where white blood cells build up in the esophagus, causing pain and swallowing problems. The drug aims to reduce inflammation and improve tissue health. Results will show if d…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Massive study probes cancer risk in EoE patients
Knowledge-focused CompletedThis completed study looked at 100,000 patient records to find out if people with eosinophilic esophagitis (EoE) are more likely to develop esophageal cancer. The researchers wanted to see if any increased risk is due to EoE itself or to other conditions like acid reflux or Barre…
Matched conditions: EOSINOPHILIC ESOPHAGITIS (EOE)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC